A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
May 22nd, 2019
Here we present a protocol to induce post-stroke depression in rats by occluding the middle cerebral artery via the internal carotid artery. We use the Porsolt forced swim test and the sucrose preference test to confirm and evaluate induced depressive moods.
Our protocol proposes a new medial cerebral artery occlusion technique in rats to help study the mechanism of post-stroke depression development and to find a more efficient therapy. The main advantage of our technique is its ability to reduce the variability in weight changes, brain edema, and infarct volume, and to minimize procedure-related deaths. After confirming a lack of response to tail pinch in a male 300 to 350-gram Sprague Dawley rat, place the animal on a 37 degrees Celsius heating plate and use a rectal probe for monitoring the core body temperature.
Apply ointment to the animal's eyes and shave the hair from the neck. Then, disinfect the exposed skin with 70 percent alcohol chlorhexidine, and cover the rat with the sterile surgical drape before performing the occlusion according to standard techniques. To obtain the neurological severity score, place an occluded rat onto a flat surface and allow the animal to move about freely.
After one minute, gently pull the rat backward by the tail and grade the animal's gait response. To measure the infarct volume, scan the prepared stained brain slices at a 1, 600 by 1, 600 dots per inch resolution and crop and standardize the scale for all of the images. Then, load the standardized images into an appropriate image analysis software program and use a tracing tool to measure the area of marked pallor in six consecutive two-millimeter slices to determine the infarct size as a percentage of the whole brain slice.
30 to 33 days after the surgery, transfer the animals to a closed, quiet, light-controlled room in individual cages, and place a bottle containing 100 milliliters of 1%sucrose solution into each cage for 24 hours. The next day, remove the bottles as well as the food and drinking water for 12 hours. At the end of the deprivation period, place one bottle containing 100 milliliters of 1%sucrose solution and one bottle containing 100 milliliters of tap water into each cage for four hours.
Then, record the volume of the sucrose solution and water consumed to allow calculation of the affinity to sucrose preference for each animal. For Porsolt's forced-swim test, 30 to 33 days after the surgery, first place each rat in a vertical plexiglass cylinder containing 80 centimeters of 25 degrees Celsius water for 15 minutes. At the end of the habituation period, allow the rat to dry for 15 minutes in the heated enclosure at 32 degrees Celsius before returning the animal to its home cage.
The next day, return the rat to the cylinder for a final five minutes, recording the five-minute test to allow calculation of the total duration of immobility during that period. Histological analysis reveals a statistically significant infarct volume as a percentage of the total brain volume post-MCAO when compared to animals in the sham control group. A statistically-significant brain edema is also observed in the experimental animals compared to the sham control group.
MCAO animals demonstrate lower neurological performances compared to sham-operated animals at 50 minutes, 24 hours, and seven days post-surgery. MCAO rats also consume a significantly lower amount of sucrose and exhibit a longer immobility during Porsalt's forced-swim tests compared to the sham-operated animals. This is an important model for behavioral stroke studies and could serve as a tool for assessing future therapies or providing critical preclinical data on the efficacy of therapeutic substances.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a protocol for inducing post-stroke depression in rats through middle cerebral artery occlusion. The study employs behavioral tests to evaluate depressive moods in the subjects.
Key Study Components
Area of Science
- Neuroscience
- Behavioral Science
- Stroke Research
Background
- Post-stroke depression is a common complication following a stroke.
- Understanding its mechanisms can aid in developing effective therapies.
- Current methods may have high variability in outcomes.
- This study aims to refine the occlusion technique to minimize variability.
Purpose of Study
- To establish a reliable model for studying post-stroke depression.
- To evaluate the effects of the new occlusion technique on depressive behaviors.
- To reduce procedure-related complications in animal models.
Methods Used
- Middle cerebral artery occlusion technique in rats.
- Behavioral assessments using the Porsolt forced swim test.
- Sucrose preference test to evaluate mood changes.
- Monitoring of physiological parameters during the procedure.
Main Results
- The new technique demonstrated reduced variability in weight changes.
- Lower incidence of brain edema and infarct volume was observed.
- Procedure-related deaths were minimized.
- Behavioral tests confirmed the induction of depressive states.
Conclusions
- The refined occlusion technique is effective for studying post-stroke depression.
- It provides a more consistent model for future research.
- Further studies are needed to explore therapeutic interventions.
Frequently Asked Questions
Executive Industry Relevance
Establishing reliable preclinical models of post-stroke depression is critical for de-risking neuropsychiatric target validation in stroke therapeutics. This MCAO technique reduces variability in infarct volume, brain edema, and mortality, enhancing predictive confidence in behavioral phenotyping. Improved model consistency supports go/no-go decisions in early discovery by clarifying mechanistic links between cerebral ischemia and depressive phenotypes.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses linking ischemic injury to depressive pathophysiology through controlled MCAO induction.
- Operational Value: Reduces outcome variability in weight changes, infarct volume, and brain edema, improving assay reproducibility for target engagement studies.
- Predictive Value: Supports phenotypic screening of compounds by providing a disease-relevant system with validated depressive-like behaviors via sucrose preference and forced swim tests.
Screening & Assay Development
- Assay Readiness: Produces standardized biological systems with quantifiable neurological severity scores and infarct volume measurements for downstream compound screening.
- Quantitative Outputs: Generates measurable endpoints including sucrose preference ratios and immobility duration, enabling dose-response analysis in therapeutic screening.
- Scalability: The ICA-based occlusion technique allows consistent model generation across cohorts, supporting platform reuse in lead identification campaigns.
Translational & Preclinical Research
- Disease Relevance: Models post-stroke depression as a comorbid neuropsychiatric complication, aligning with clinical PSD prevalence and therapeutic unmet need.
- Translational Continuity: Connects discovery-phase mechanistic de-risking to preclinical validation through behavioral and histological confirmation of depressive states.
- Risk-Adjusted Advancement: Provides preclinical data on therapeutic efficacy by correlating MCAO-induced infarct volume with behavioral outcomes, informing go/no-go decisions.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification to preclinical efficacy testing, enabling iterative refinement of stroke-neuropsychiatric therapeutic hypotheses.
- Discovery Biology: Supports hypothesis testing of ischemic stroke mechanisms driving depressive phenotypes via controlled MCAO and neurological scoring.
- Screening: Enables assay standardization through reproducible infarct volume and brain edema measurements, critical for compound library screening.
- Analytics: Delivers quantitative dependent variables including sucrose consumption and immobility duration, facilitating statistical comparison across treatment groups.
- Translational Research: Links ischemic lesion burden to behavioral phenotypes, supporting biomarker alignment between infarct volume and depressive-like outcomes.
- Enterprise Reuse: Establishes a reusable preclinical platform for evaluating neuroprotective and antidepressant candidates in stroke comorbidity models.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by reducing mechanistic ambiguity in stroke-depression comorbidity models.
- Operational Value: Enhances reproducibility and standardization across laboratories through minimized procedure-related deaths and variability.
- Strategic Value: Improves capital efficiency by reducing false positives in lead identification via biologically de-risked models.
- Portfolio Impact: Enables risk-adjusted prioritization of stroke therapeutics targeting neuropsychiatric comorbidities based on consistent phenotypic readouts.
Implementation Considerations
- Requires expertise in rodent stereotaxic surgery and neurological severity scoring.
- Dependent on instrumentation for infarct volume quantification via image analysis of stained brain slices.
- Necessitates cross-team standardization of sucrose preference and forced swim test protocols for behavioral endpoints.
- Adaptation considerations include scaling the ICA occlusion technique across rat strains and ages while monitoring core temperature.
- Practical limitations include the need for postoperative monitoring to confirm infarct development and behavioral changes at 30–33 days post-MCAO.
